Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries AbbVie (NY: ABBV ) 162.39 +0.87 (+0.54%) Streaming Delayed Price Updated: 12:04 PM EDT, Apr 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,446,175 Open 161.27 Bid (Size) 162.34 (2) Ask (Size) 162.40 (2) Prev. Close 161.52 Today's Range 159.69 - 162.53 52wk Range 130.96 - 182.89 Shares Outstanding N/A Dividend Yield 3.65% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Inflation-Proof Fortunes: 7 Dividend Aristocrats to Keep Your Wealth Growing Today 6:32 EDT These dividend aristocrat stocks can protect tired consumers from persistent inflation through dividends that outpace recent spikes. Via InvestorPlace Topics Economy Exposures Interest Rates AbbVie Outlook: Why Humira Biosimilars Won't Undo A Projected $73 Billion In Sales April 29, 2024 The company is projected to bring in increasing sales through at least 2029. Via Investor's Business Daily Performance YTD +1.61% +1.61% 1 Month -10.16% -10.16% 3 Month -0.93% -0.93% 6 Month +14.45% +14.45% 1 Year +5.65% +5.65% More News Read More Peeling Back The Layers: Exploring AbbVie Through Analyst Insights April 29, 2024 Via Benzinga Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week April 29, 2024 Via Benzinga Topics Stocks Exposures US Equities Better Dividend Stock: AbbVie or Johnson & Johnson? April 28, 2024 Via The Motley Fool 3 Dividend Stocks to Buy and Hold for the Next Decade April 27, 2024 Via The Motley Fool AbbVie's Options Frenzy: What You Need to Know April 23, 2024 Via Benzinga Why AbbVie Stock Stumbled Today Despite the Earnings Beat April 26, 2024 Via The Motley Fool AbbVie (ABBV) Q1 2024 Earnings Call Transcript April 26, 2024 Via The Motley Fool Topics Earnings Exposures Financial Arthritis Patients - Cigna's Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Cost April 26, 2024 Via Benzinga Tech Stocks Rebound As Magnificent 7 Roar On Strong Earnings, Energy Giants Tumble: What's Driving Markets Friday? April 26, 2024 Via Benzinga Topics Economy Exposures Interest Rates ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q1 2024 April 26, 2024 Via InvestorPlace Ex-Humira Growth Platform Drives AbbVie's Q1 Performance, Drugmaker Lifts Annual Profit Outlook April 26, 2024 Via Benzinga AbbVie Beats First-Quarter Views As Skyrizi Looks To Take Humira's Title April 26, 2024 Via Investor's Business Daily Wall Street Futures Ride High On Microsoft, Alphabet Cheer, But Will Inflation Data Burst The Bubble? Why This Analyst Thinks Bull Run Isn't Over Yet April 26, 2024 Via Benzinga Topics Economy Exposures Interest Rates AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study April 25, 2024 Via Benzinga 3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition April 25, 2024 Via InvestorPlace Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes April 23, 2024 Via InvestorPlace Buying the Dip in These 3 Undervalued Dividend Stocks April 22, 2024 Via The Motley Fool 3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip April 22, 2024 Via InvestorPlace Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week April 21, 2024 Via Benzinga Why I Keep Buying This Ultra-High-Yielding ETF for Passive Income April 20, 2024 Via The Motley Fool Topics ETFs These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher? April 19, 2024 Via InvestorPlace The Bad News Heading Into AbbVie's First-Quarter Earnings Report April 19, 2024 Via Investor's Business Daily Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study April 18, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
